DARS1
Basic information
Region (hg38): 2:135905881-135986100
Previous symbols: [ "DARS" ]
Links
Phenotypes
GenCC
Source:
- hypomyelination with brain stem and spinal cord involvement and leg spasticity (Definitive), mode of inheritance: AR
- hypomyelination with brain stem and spinal cord involvement and leg spasticity (Supportive), mode of inheritance: AR
- hypomyelination with brain stem and spinal cord involvement and leg spasticity (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hypomyelination with brainstem and spinal cord involvement and leg spasticity | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 23643384 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DARS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 27 | 28 | ||||
missense | 61 | 68 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 5 | 13 | 3 | 21 | ||
non coding | 27 | 16 | 45 | |||
Total | 1 | 3 | 72 | 57 | 17 |
Highest pathogenic variant AF is 0.0000197
Variants in DARS1
This is a list of pathogenic ClinVar variants found in the DARS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-135907329-C-T | Hypomyelination with brain stem and spinal cord involvement and leg spasticity • Inborn genetic diseases | Uncertain significance (Nov 09, 2023) | ||
2-135907330-G-A | Uncertain significance (Jan 20, 2020) | |||
2-135907332-T-G | Inborn genetic diseases | Uncertain significance (Mar 03, 2021) | ||
2-135907336-G-C | Uncertain significance (Apr 10, 2022) | |||
2-135907341-C-T | Hypomyelination with brain stem and spinal cord involvement and leg spasticity | Likely pathogenic (May 03, 2020) | ||
2-135907342-G-A | Uncertain significance (Aug 24, 2022) | |||
2-135907342-G-C | Hypomyelination with brain stem and spinal cord involvement and leg spasticity | Pathogenic (May 02, 2013) | ||
2-135907362-C-T | Uncertain significance (Jul 18, 2022) | |||
2-135907363-G-A | Hypomyelination with brain stem and spinal cord involvement and leg spasticity | Conflicting classifications of pathogenicity (Oct 17, 2022) | ||
2-135907381-G-C | Inborn genetic diseases | Uncertain significance (Nov 29, 2023) | ||
2-135907390-T-G | Inborn genetic diseases | Uncertain significance (Dec 14, 2021) | ||
2-135907396-C-T | Uncertain significance (Jan 15, 2022) | |||
2-135907405-A-G | not specified | Benign (Jan 24, 2024) | ||
2-135911120-A-C | Likely benign (Sep 06, 2022) | |||
2-135911121-G-A | not specified | Benign (Jan 21, 2024) | ||
2-135911162-G-A | Conflicting classifications of pathogenicity (Nov 01, 2023) | |||
2-135911173-G-A | Likely benign (Sep 26, 2022) | |||
2-135911174-C-T | Hypomyelination with brain stem and spinal cord involvement and leg spasticity | Pathogenic (May 02, 2013) | ||
2-135911179-G-C | DARS1-related disorder | Likely benign (Jun 13, 2019) | ||
2-135911217-A-G | Likely benign (Dec 02, 2021) | |||
2-135911217-A-T | Likely benign (Dec 30, 2022) | |||
2-135911368-T-C | not specified | Benign (Jan 15, 2024) | ||
2-135911368-TTTAAG-T | Likely benign (Mar 18, 2022) | |||
2-135911370-T-C | Likely benign (Oct 17, 2022) | |||
2-135911399-GCT-G | Uncertain significance (Oct 05, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DARS1 | protein_coding | protein_coding | ENST00000264161 | 16 | 79424 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000854 | 0.999 | 125718 | 0 | 28 | 125746 | 0.000111 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.747 | 235 | 270 | 0.872 | 0.0000136 | 3291 |
Missense in Polyphen | 88 | 109.9 | 0.80072 | 1328 | ||
Synonymous | 0.107 | 87 | 88.3 | 0.986 | 0.00000444 | 906 |
Loss of Function | 2.96 | 14 | 32.1 | 0.436 | 0.00000170 | 388 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000248 | 0.000245 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000163 | 0.000158 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.0000330 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. {ECO:0000250|UniProtKB:P15178}.;
- Pathway
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human);Hypoacetylaspartia;Aspartate Metabolism;Canavan Disease;Alanine and aspartate metabolism;tRNA Aminoacylation;Alanine Aspartate Asparagine metabolism;Translation;Metabolism of proteins;Metabolism of amino acids and derivatives;Metabolism;tRNA charging;Selenoamino acid metabolism;SeMet incorporation into proteins;Cytosolic tRNA aminoacylation
(Consensus)
Recessive Scores
- pRec
- 0.196
Intolerance Scores
- loftool
- 0.456
- rvis_EVS
- 0.26
- rvis_percentile_EVS
- 70.44
Haploinsufficiency Scores
- pHI
- 0.634
- hipred
- Y
- hipred_score
- 0.706
- ghis
- 0.588
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.992
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dars
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- translation;tRNA aminoacylation for protein translation;aspartyl-tRNA aminoacylation;protein-containing complex assembly
- Cellular component
- cytoplasm;cytosol;membrane;aminoacyl-tRNA synthetase multienzyme complex;synapse;extracellular exosome
- Molecular function
- RNA binding;aminoacylase activity;aspartate-tRNA ligase activity;protein binding;ATP binding